» Articles » PMID: 24265969

Depression Among HIV-infected Patients in Korea: Assessment of Clinical Significance and Risk Factors

Overview
Date 2013 Nov 23
PMID 24265969
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: With prolonged life expectancies, mental illness has emerged as a disabling disorder among people with HIV.

Materials And Methods: This study was conducted to assess the prevalence of depression and its risk factors among Korean patients with HIV infections. Eighty-two HIV-infected patients completed structured questionnaires including the Beck Depression Inventory and the State-Trait Anxiety Inventory. Subjects with depression were compared to those without depression in terms of demographics, comorbidities, CD4 T-cell count, RNA copy numbers, highly active antiretroviral therapy (HAART) regimens, and adherence.

Results: The estimated depression rate was 21% (17 of 82 subjects). Comorbidities (47% vs. 20%, P = 0.01) and unemployment (65% vs. 31%, P = 0.02) were risk factors for depression. Depressive patients were more likely to be anxious (71% vs. 29%, P < 0.01), to frequently miss clinical appointments each year (P = 0.04), and to have higher cumulative time lost to follow-up per month (P <0.01) compared to non-depressive patients. Only three depressive patients were referred to neuropsychologists.

Conclusions: More than 20% of the Korean HIV patients in this study suffered from depression associated with poor adherence. Considering the low level of recognition of depression by clinicians, risk factor-based active assessment is recommended to manage depression properly in HIV-infected patients.

Citing Articles

Mental health disparities in people living with human immunodeficiency virus: A cross-sectional study on physician-patient concordance and treatment regimens.

Shi J, Zhang Z, Zhang J, Zhang Y, Qiu J, Liu F Chin Med J (Engl). 2024; .

PMID: 39164815 PMC: 11407812. DOI: 10.1097/CM9.0000000000003202.


Identifying the Unmet Medical Needs of HIV-Positive Subjects in Korea: Results of a Nationwide Online Survey.

Lee J, Kim Y, Lee J, Park S, Choi J Infect Chemother. 2023; 55(3):397-402.

PMID: 37794578 PMC: 10551716. DOI: 10.3947/ic.2023.0065.


Analysis of Factors Influencing Depression in Elderly People Living with HIV/AIDS Based on Structural Equation Model: A Cross-Sectional Study in Guangxi, China.

He K, Zhang X, Yang D, Fu X, Chen Y, Chen Z J Multidiscip Healthc. 2023; 16:1491-1501.

PMID: 37274427 PMC: 10238549. DOI: 10.2147/JMDH.S410538.


Prevalence and Risks of Depression and Substance Use Among Adults Living with HIV in the Asia-Pacific Region.

Ross J, Jiamsakul A, Avihingsanon A, Lee M, Ditangco R, Choi J AIDS Behav. 2022; 26(12):3862-3877.

PMID: 35668223 PMC: 9170121. DOI: 10.1007/s10461-022-03714-5.


Prevalence of mental health conditions among people living with HIV during the COVID-19 pandemic: A rapid systematic review and meta-analysis.

Lee K, Ang C, Lim S, Siau C, Ong L, Ching S HIV Med. 2022; 23(9):990-1001.

PMID: 35304829 PMC: 9111307. DOI: 10.1111/hiv.13299.


References
1.
Adewuya A, Afolabi M, Ola B, Ogundele O, Ajibare A, Oladipo B . Relationship between depression and quality of life in persons with HIV infection in Nigeria. Int J Psychiatry Med. 2008; 38(1):43-51. DOI: 10.2190/PM.38.1.d. View

2.
Valente S . Depression and HIV disease. J Assoc Nurses AIDS Care. 2003; 14(2):41-51. DOI: 10.1177/1055329002250993. View

3.
Osborn C, Egede L . The relationship between depressive symptoms and medication nonadherence in type 2 diabetes: the role of social support. Gen Hosp Psychiatry. 2012; 34(3):249-53. PMC: 3345067. DOI: 10.1016/j.genhosppsych.2012.01.015. View

4.
Garcia de Olalla P, Knobel H, Carmona A, Guelar A, Lopez-Colomes J, Cayla J . Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002; 30(1):105-10. DOI: 10.1097/00042560-200205010-00014. View

5.
Gonzalez J, Batchelder A, Psaros C, Safren S . Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011; 58(2):181-7. PMC: 3858003. DOI: 10.1097/QAI.0b013e31822d490a. View